Search hospitals > Michigan > Warren

Macomb Hematology Oncology PC

Claim this profile
Warren, Michigan 48093
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
139 reported clinical trials
6 medical researchers
Photo of Macomb Hematology Oncology PC in WarrenPhoto of Macomb Hematology Oncology PC in WarrenPhoto of Macomb Hematology Oncology PC in Warren

Summary

Macomb Hematology Oncology PC is a medical facility located in Warren, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Macomb Hematology Oncology PC is involved with conducting 139 clinical trials across 302 conditions. There are 6 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.

Area of expertise

1Lung Cancer
Global Leader
Macomb Hematology Oncology PC has run 30 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage I
2Breast Cancer
Global Leader
Macomb Hematology Oncology PC has run 23 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
Stage IV
ER positive

Top PIs

Clinical Trials running at Macomb Hematology Oncology PC

Bladder Cancer
Lung Cancer
Breast Cancer
Esophageal cancer
Multiple Myeloma
Breast cancer
Bladder Carcinoma
Prostate Cancer
Gastric cancer
Cutaneous Melanoma
Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Image of trial facility.

Gemcitabine + Cisplatin

for Bladder Cancer

This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting1 award Phase 2
Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting1 award N/A9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Macomb Hematology Oncology PC?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security